Abstract
Objective
The objective of this study is to assess the HPV vaccination coverage of 11–19-year-old girls during a state-coordinated HPV vaccination program in Geneva, Switzerland, from September 2008 to June 2011.
Methods
State Medical Office coordinated the HPV vaccination program. Each service provider transmitted the list of the persons who had received their first, second, or third shot.
Results
The global coverage rates, 3 years after the program had been launched, were 63.72% for one dose, 63.22% for two doses, and 61.40% for three doses of the HPV vaccine.
Conclusion
This study shows that it is possible to obtain a good coverage rates after 3 years of a state-coordinated HPV vaccination program.
References
Berry-Caban CS, Buenaventura JB (2009) HPV vaccination coverage among adolescents aged 9 to 17 years in a United States military treatment facility. Int J Adolesc Med Health 21(4):567–570
Brabin L, Roberts SA, Stretch R, Baxter D, Chambers G, Kitchener H, McCann R (2008) Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study. BMJ 336(7652):1056–1058
Brotherton JM, Deeks SL, Campbell-Lloyd S, Misrachi A, Passaris I, Peterson K, Pitcher H, Scully M, Watson M, Webby R (2008) Interim estimates of human papillomavirus vaccination coverage in the school-based program in Australia. Commun Dis Intell 32(4):457–461
Canfell K (2010) Monitoring HPV vaccination programmes. BMJ 340:c1666
Center of Disease and Control (2008) StatBite: HPV vaccination among U.S. girls aged 13-17 years in 2007. J Natl Cancer Inst 100(22):1570
Dorell CG, Yankey D, Santibanez TA, Markowitz LE (2011) Human papillomavirus vaccination series initiation and completion, 2008–2009. Pediatrics 128(5):830–839. doi:10.1542/peds.2011-0950
Office Fedérale de la Santé Publique (2008a) Recommandations de vaccination contre les papillomavirus humains (HPV)
Office Fedérale de la Santé Publique (2008b) Vaccination contre le cancer du col de l’utérus - but des programmes cantonaux de vaccination
Registre des tumeurs (2009) Le cancer à Geneve
Rouzier R, Giordanella JP (2010) Coverage and compliance of Human Papilloma Virus vaccines in Paris: demonstration of low compliance with non-school-based approaches. J Adolesc Health 47(3):237–241
Simoens C, Sabbe M, Van DP, Beutels P, Arbyn M (2009) Introduction of human papillomavirus (HPV) vaccination in Belgium, 2007–2008. EuroSurveill 14(46)
Smith LM, Brassard P, Kwong JC, Deeks SL, Ellis AK, Levesque LE (2011) Factors associated with initiation and completion of the quadrivalent human papillomavirus vaccine series in an ontario cohort of grade 8 girls. BMC Public Health 11:645. doi:10.1186/1471-2458-11-645
StataCorp (2007) Stata 10
Wong CA, Berkowitz Z, Dorell CG, Anhang Price R, Lee J, Saraiya M (2011) Human papillomavirus vaccine uptake among 9- to 17-year-old girls: National Health Interview Survey, 2008. Cancer 117(24):5612–5620. doi:10.1002/cncr.26246
Woringer V (2010) Etude de la couverture vaccinale dans le canton de Vaud après la première campagne de vaccination contre le papillomavirus (HPV), année scolaire 2008–2009
World Health Organisation (2005) Report of the consultation on human papillomavirus vaccines
Acknowledgments
The authors thank Clotilde and Clémence DELPECH for they help in the proofreading of this article.
Conflict of interest
The authors declare that they have no competing interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jeannot, E., Sudre, P. & Chastonay, P. HPV vaccination coverage within 3 years of program launching (2008–2011) at Geneva State, Switzerland. Int J Public Health 57, 629–632 (2012). https://doi.org/10.1007/s00038-012-0352-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00038-012-0352-2